Strengthening Canada’s Influenza Research Capabilities

PCIRN, a national network of key influenza vaccine researchers, develops and tests methodologies related to the evaluation of influenza vaccines as they pertain to safety, immunogenicity and effectiveness, and program implementation and evaluation.

Learn More

PHAC/CIHR INFLUENZA RESEARCH NETWORK

On June 5, 2009, the Minister of Health announced $10.8 million over three years to support the PHAC/CIHR Influenza Research Network (PCIRN). The network was originally designed to carry out a three-year plan to develop and test procedures for evaluating a pandemic vaccine using seasonal influenza vaccine as a model. On June 6, 2009, WHO declared a global H1N1/09 influenza pandemic, and in response, PCIRN investigators began planning for the evaluation of an H1N1/09 vaccine expected to be available in the Fall. To support this work, PHAC approved an additional $2.7 million over three years to accelerate the network’s activities.

PCIRN is a strong collaboration of leading vaccine researchers and institutions. After just over two years of operation, PCIRN represents over 100 investigators at more than 30 institutions, including universities, hospitals, and provincial and regional agencies across Canada.

PUBLICATIONS AND KNOWLEDGE TRANSLATION

INFLUENZA IMMUNIZATION DATA: CAN WE MAKE ORDER OUT OF CHAOS?

The 2009 H1N1 pandemic vaccination campaign was an excellent opportunity to witness...

VIEW PUBLICATION

PERCEPTIONS OF FRONTLINE STAFF REGARDING DATA COLLECTION

Collecting individual-level information at the point of
vaccination enables...

VIEW PUBLICATION

 

 

 

 

 

STRATEGIES FOR sUCCESSFUL RAPID TRIALS OF INFLUENZA VACCINE

In contrast to the gradual pace of conventional vaccine trials..

VIEW PUBLICATION